Dordaneh Sugano1, Abhinav Sidana1, Amit L Jain2, Brian Calio1, Sonia Gaur3, Mahir Maruf1, Maria Merino4, Peter Choyke3, Baris Turkbey3, Bradford J Wood5, Peter A Pinto1. 1. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 3-1621 NW, Bethesda, MD, 20814, USA. 2. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 3-1621 NW, Bethesda, MD, 20814, USA. jain.amitlodha@gmail.com. 3. Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 4. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 5. National Cancer Institute and Clinical Center, Center for Interventional Oncology, National Institutes of Health, Bethesda, MD, USA.
Abstract
PURPOSE: Index tumor volume (ITV) measured on radical prostatectomy (RP) specimens has been shown to be associated with adverse pathologic and oncologic outcomes. We evaluate the value of ITV calculated from prostate multiparametric MRI (mpMRI) in predicting adverse clinical and pathologic outcomes. MATERIALS AND METHODS: Data from a prospectively maintained, single-institution database were analyzed for patients who underwent mpMRI prior to RP (2007-2016). Index tumor was defined as a T2-visible lesion with the longest diameter. Adverse pathologic outcomes were extraprostatic extension (EPE), lymph node invasion (LNI), seminal vesicle invasion (SVI), and positive margins (PM). Logistic and Cox proportional hazard regression were used to assess associations with adverse pathology and biochemical recurrence (BCR), respectively. RESULTS: Of the 455 patients included, EPE, LNI, SVI and PM were present in 23.5%, 6.2%, 5.5% and 15.7% patients, respectively. Patients with adverse pathologic outcomes had larger median ITV. ITV was found to be an independent predictor of EPE (OR 1.22, p = 0.010), LNI (OR 1.39, p = 0.001), and SVI (OR 1.28, p = 0.009), but not PM (OR 1.03, p = 0.522). Combination of ITV and PSA was found to have predictive ability comparable to that of modified Partin tables (EPE:ITV + PSAAUC = 0.71 vs. PartinAUC = 0.71; LNI:ITV + PSAAUC = 0.92 vs. PartinAUC = 0.90, SVI:ITV + PSAAUC = 0.78 vs. PartinAUC = 0.82). 5 year BCR-free survival (median follow-up 24.9 months) was higher for patients with ITV < 2 cc (84.1% vs. 58.5%, p = 0.001). However, ITV was not found to be an independent predictor of BCR (HR 1.69, p = 0.130). CONCLUSIONS: We demonstrate that ITV measured on mpMRI is a predictor of adverse pathologic and clinical outcomes and can aid in preoperative risk assessment.
PURPOSE: Index tumor volume (ITV) measured on radical prostatectomy (RP) specimens has been shown to be associated with adverse pathologic and oncologic outcomes. We evaluate the value of ITV calculated from prostate multiparametric MRI (mpMRI) in predicting adverse clinical and pathologic outcomes. MATERIALS AND METHODS: Data from a prospectively maintained, single-institution database were analyzed for patients who underwent mpMRI prior to RP (2007-2016). Index tumor was defined as a T2-visible lesion with the longest diameter. Adverse pathologic outcomes were extraprostatic extension (EPE), lymph node invasion (LNI), seminal vesicle invasion (SVI), and positive margins (PM). Logistic and Cox proportional hazard regression were used to assess associations with adverse pathology and biochemical recurrence (BCR), respectively. RESULTS: Of the 455 patients included, EPE, LNI, SVI and PM were present in 23.5%, 6.2%, 5.5% and 15.7% patients, respectively. Patients with adverse pathologic outcomes had larger median ITV. ITV was found to be an independent predictor of EPE (OR 1.22, p = 0.010), LNI (OR 1.39, p = 0.001), and SVI (OR 1.28, p = 0.009), but not PM (OR 1.03, p = 0.522). Combination of ITV and PSA was found to have predictive ability comparable to that of modified Partin tables (EPE:ITV + PSAAUC = 0.71 vs. PartinAUC = 0.71; LNI:ITV + PSAAUC = 0.92 vs. PartinAUC = 0.90, SVI:ITV + PSAAUC = 0.78 vs. PartinAUC = 0.82). 5 year BCR-free survival (median follow-up 24.9 months) was higher for patients with ITV < 2 cc (84.1% vs. 58.5%, p = 0.001). However, ITV was not found to be an independent predictor of BCR (HR 1.69, p = 0.130). CONCLUSIONS: We demonstrate that ITV measured on mpMRI is a predictor of adverse pathologic and clinical outcomes and can aid in preoperative risk assessment.
Entities:
Keywords:
Biomarkers; Magnetic resonance imaging; PSA; Prostatic neoplasms; Tumor volume
Authors: Michael S Cookson; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine Tangen; J Brantley Thrasher; Ian Thompson Journal: J Urol Date: 2007-02 Impact factor: 7.450
Authors: Heather J Chalfin; Michael Dinizo; Bruce J Trock; Zhaoyong Feng; Alan W Partin; Patrick C Walsh; Elizabeth Humphreys; Misop Han Journal: BJU Int Date: 2012-07-12 Impact factor: 5.588
Authors: Baris Turkbey; Haresh Mani; Omer Aras; Ardeshir R Rastinehad; Vijay Shah; Marcelino Bernardo; Thomas Pohida; Dagane Daar; Compton Benjamin; Yolanda L McKinney; W Marston Linehan; Bradford J Wood; Maria J Merino; Peter L Choyke; Peter A Pinto Journal: J Urol Date: 2012-08-15 Impact factor: 7.450
Authors: D M Somford; E H Hamoen; J J Fütterer; J P van Basten; C A Hulsbergen-van de Kaa; W Vreuls; I M van Oort; H Vergunst; L A Kiemeney; J O Barentsz; J A Witjes Journal: J Urol Date: 2013-05-13 Impact factor: 7.450
Authors: Stephen A Boorjian; R Jeffrey Karnes; Paul L Crispen; Rachel E Carlson; Laureano J Rangel; Eric J Bergstralh; Michael L Blute Journal: J Urol Date: 2010-01-21 Impact factor: 7.450
Authors: Christian P Meyer; Jens Hansen; Katharina Boehm; Derya Tilki; Firas Abdollah; Quoc-Dien Trinh; Margit Fisch; Guido Sauter; Markus Graefen; Hartwig Huland; Felix K H Chun; Sascha A Ahyai Journal: World J Urol Date: 2016-06-03 Impact factor: 4.226
Authors: James S Wysock; Neil Mendhiratta; Fabio Zattoni; Xiaosong Meng; Marc Bjurlin; William C Huang; Herbert Lepor; Andrew B Rosenkrantz; Samir S Taneja Journal: BJU Int Date: 2016-02-25 Impact factor: 5.588
Authors: Richard Ho; Mohummad M Siddiqui; Arvin K George; Thomas Frye; Amichai Kilchevsky; Michele Fascelli; Nabeel A Shakir; Raju Chelluri; Steven F Abboud; Annerleim Walton-Diaz; Sandeep Sankineni; Maria J Merino; Baris Turkbey; Peter L Choyke; Bradford J Wood; Peter A Pinto Journal: PLoS One Date: 2016-06-23 Impact factor: 3.240
Authors: Se Young Choi; Byung Hoon Chi; Bumjin Lim; Yoon Soo Kyung; Dalsan You; In Gab Jeong; Cheryn Song; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim Journal: J Cancer Res Clin Oncol Date: 2020-01-08 Impact factor: 4.553